Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone + ropivacaine TAP block for post‑cesarean analgesia
ChiCTR2500104995Phase 4Not yet recruiting
- Sponsor
- Shengli Oilfield Central Hospital
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in postoperative pain (2 arms), sponsored by Shengli Oilfield Central Hospital. Primary endpoints: Postoperative pain level (VAS) and Postoperative comfort level (BCS). Planned start Jun 2025; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500104995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104995.